Jane Street’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-187,709
| Closed | -$3.55M | – | 13052 |
|
|
2026
Q1 | $4.08M | Buy |
+187,709
| New | +$3.63M | ﹤0.01% | 3813 |
|
|
2025
Q3 | – | Sell |
-676,277
| Closed | -$12.1M | – | 11721 |
|
|
2025
Q2 | $11.6M | Buy |
676,277
+521,225
| +336% | +$22.2M | ﹤0.01% | 1977 |
|
|
2025
Q1 | $9.9M | Buy |
155,052
+103,738
| +202% | +$10.9M | ﹤0.01% | 1999 |
|
|
2024
Q4 | $6.24M | Buy |
51,314
+7,316
| +17% | +$897K | ﹤0.01% | 2383 |
|
|
2024
Q3 | $5.49M | Sell |
43,998
-825,131
| -95% | -$114M | ﹤0.01% | 2704 |
|
|
2024
Q2 | $137M | Buy |
869,129
+591,025
| +213% | +$75.9M | 0.03% | 299 |
|
|
2024
Q1 | $36M | Buy |
278,104
+95,472
| +52% | +$11.7M | 0.01% | 802 |
|
|
2023
Q4 | $17.6M | Buy |
182,632
+98,280
| +117% | +$9.43M | ﹤0.01% | 1388 |
|
|
2023
Q3 | $10.2M | Sell |
84,352
-58,531
| -41% | -$6.62M | ﹤0.01% | 1745 |
|
|
2023
Q2 | $16.4M | Buy |
142,883
+2,393
| +2% | +$309K | 0.01% | 1416 |
|
|
2023
Q1 | $19.4M | Sell |
140,490
-33,674
| -19% | -$4.37M | 0.01% | 1034 |
|
|
2022
Q4 | $22.6M | Buy |
174,164
+85,327
| +96% | +$9.89M | 0.01% | 916 |
|
|
2022
Q3 | $9.82M | Buy |
88,837
+7,963
| +10% | +$803K | ﹤0.01% | 1713 |
|
|
2022
Q2 | $6.06M | Buy |
80,874
+63,482
| +365% | +$4.67M | ﹤0.01% | 2382 |
|
|
2022
Q1 | $1.36M | Sell |
17,392
-148,032
| -89% | -$11.3M | ﹤0.01% | 5483 |
|
|
2021
Q4 | $14.9M | Buy |
165,424
+44,998
| +37% | +$3.85M | ﹤0.01% | 1449 |
|
|
2021
Q3 | $11.1M | Buy |
120,426
+79,201
| +192% | +$6.1M | ﹤0.01% | 1675 |
|
|
2021
Q2 | $3.21M | Sell |
41,225
-126,321
| -75% | -$9.58M | ﹤0.01% | 3456 |
|
|
2021
Q1 | $12.5M | Buy |
167,546
+114,298
| +215% | +$10.5M | 0.01% | 1348 |
|
|
2020
Q4 | $9.08M | Buy |
53,248
+34,451
| +183% | +$5.1M | ﹤0.01% | 1494 |
|
|
2020
Q3 | $2.64M | Buy |
18,797
+2,999
| +19% | +$456K | ﹤0.01% | 2615 |
|
|
2020
Q2 | $2.53M | Buy |
15,798
+3,094
| +24% | +$421K | ﹤0.01% | 2736 |
|
|
2020
Q1 | $1.24M | Buy |
12,704
+8,069
| +174% | +$922K | ﹤0.01% | 2543 |
|
|
2019
Q4 | $598K | Sell |
4,635
-1,969
| -30% | -$199K | ﹤0.01% | 3469 |
|
|
2019
Q3 | $498K | Sell |
6,604
-147,490
| -96% | -$17.4M | ﹤0.01% | 3549 |
|
|
2019
Q2 | $23.4M | Buy |
154,094
+108,092
| +235% | +$13.1M | 0.04% | 331 |
|
|
2019
Q1 | $5.48M | Buy |
46,002
+29,395
| +177% | +$3.78M | 0.01% | 1077 |
|
|
2018
Q4 | $1.81M | Buy |
16,607
+13,248
| +394% | +$1.66M | ﹤0.01% | 1858 |
|
|
2018
Q3 | $543K | Sell |
3,359
-133,903
| -98% | -$18.3M | ﹤0.01% | 3511 |
|
|
2018
Q2 | $18.1M | Buy |
137,262
+110,975
| +422% | +$10.5M | 0.04% | 341 |
|
|
2018
Q1 | $1.95M | Sell |
26,287
-1,320
| -5% | -$88K | 0.01% | 1884 |
|
|
2017
Q4 | $1.54M | Sell |
27,607
-39,587
| -59% | -$2.1M | ﹤0.01% | 1850 |
|
|
2017
Q3 | $3.05M | Buy |
67,194
+45,143
| +205% | +$1.8M | 0.01% | 1230 |
|
|
2017
Q2 | $743K | Buy |
+22,051
| New | +$718K | ﹤0.01% | 2538 |
|
|
2017
Q1 | – | Sell |
-24,120
| Closed | -$746K | – | 4647 |
|
|
2016
Q4 | $662K | Sell |
24,120
-44,227
| -65% | -$1.78M | ﹤0.01% | 2539 |
|
|
2016
Q3 | $4.2M | Buy |
68,347
+29,800
| +77% | +$901K | 0.02% | 692 |
|
|
2016
Q2 | $736K | Sell |
38,547
-27,994
| -42% | -$519K | ﹤0.01% | 2347 |
|
|
2016
Q1 | $1.3M | Buy |
66,541
+3,528
| +6% | +$61.6K | 0.01% | 1605 |
|
|
2015
Q4 | $2.43M | Buy |
63,013
+5,005
| +9% | +$162K | 0.02% | 912 |
|
|
2015
Q3 | $1.86M | Buy |
58,008
+3,314
| +6% | +$112K | 0.01% | 1055 |
|
|
2015
Q2 | $1.66M | Buy |
54,694
+37,651
| +221% | +$770K | 0.01% | 1127 |
|
|
2015
Q1 | $226K | Buy |
+17,043
| New | +$227K | ﹤0.01% | 2774 |
|
|
2014
Q1 | – | Sell |
-11,153
| Closed | -$227K | – | 3044 |
|
|
2013
Q4 | $227K | Sell |
11,153
-130,856
| -92% | -$3.89M | ﹤0.01% | 1919 |
|
|
2013
Q3 | $6.71M | Buy |
142,009
+135,494
| +2,080% | +$5.22M | 0.08% | 183 |
|
|
2013
Q2 | $248K | Buy |
+6,515
| New | +$233K | ﹤0.01% | 2060 |
|
Other funds holding SRPT
EAM
Jane Street's SRPT Position: Q2 2026 in Review
Jane Street sold out of Sarepta Therapeutics (SRPT) in Q2 2026, closing a stake of 187,709 shares — an estimated $3.55M sold.
Jane Street first reported a position in SRPT in Q2 2013 and held it in 45 quarters. The position peaked at $137M in Q2 2024. 298 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.
- Jane Street reported no remaining Sarepta Therapeutics position as of Q2 2026 after selling out during the quarter.
- Jane Street sold 187,709 Sarepta Therapeutics shares in Q2 2026, an estimated $3.55M.
- Jane Street first reported a position in Sarepta Therapeutics in Q2 2013 and held it in 45 quarters.
- Jane Street's Sarepta Therapeutics position peaked at $137M in Q2 2024.
- 298 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.